123 related articles for article (PubMed ID: 38781221)
1. Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials.
Ran T; Chen J; She Q; Mu Y; Zhang M; Mao M; Zuo Z; Li J
PLoS One; 2024; 19(5):e0303208. PubMed ID: 38781221
[TBL] [Abstract][Full Text] [Related]
2. Anthracyclines and the risk of arrhythmias: A systematic review and meta-analysis.
Dean YE; Dahshan H; Motawea KR; Khalifa Z; Tanas Y; Rakha I; Hasan W; Kishk M; Mahmoud A; Elsayed A; Abdelkader O; Tokunaga A; Khalifa A; Helmy A; Elhalag RH; Farghaly RM; Abdelkader OKS; Shah J; Hakim D; Aiash H
Medicine (Baltimore); 2023 Nov; 102(46):e35770. PubMed ID: 37986405
[TBL] [Abstract][Full Text] [Related]
3. Role of taxane and anthracycline combination regimens in the management of advanced breast cancer: a meta-analysis of randomized trials.
Zheng R; Han S; Duan C; Chen K; You Z; Jia J; Lin S; Liang L; Liu A; Long H; Wang S
Medicine (Baltimore); 2015 May; 94(17):e803. PubMed ID: 25929935
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant therapy with
Zhu J; Min N; Chen Y; Li X
Ann Transl Med; 2023 Mar; 11(5):200. PubMed ID: 37007556
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting: a 10-year single institution experience.
Testore F; Milanese S; Ceste M; de Conciliis E; Parello G; Lanfranco C; Manfredi R; Ferrero G; Simoni C; Miglietta L; Ferro S; Giaretto L; Bosso G
Am J Cardiovasc Drugs; 2008; 8(4):257-63. PubMed ID: 18690759
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?
Shah AN; Gradishar WJ
Oncologist; 2018 Oct; 23(10):1153-1161. PubMed ID: 30120159
[TBL] [Abstract][Full Text] [Related]
8. Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis.
Alizadehasl A; Ghadimi N; Kaveh S; Maleki M; Ghavamzadeh A; Noohi F; Hosseinifard H
Int J Clin Pharm; 2021 Feb; 43(1):25-34. PubMed ID: 32910372
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of dexrazoxane effect on preventing acute cardiac arrhythmia in patients with breast cancer treated with neoadjuvant/adjuvant anthracycline-based chemotherapy.
Kaplan O; Bozdag Kaplan N
Int J Clin Pract; 2021 Nov; 75(11):e14705. PubMed ID: 34363726
[TBL] [Abstract][Full Text] [Related]
10. Role and efficacy of capecitabine in the anthracycline-free regimen in breast cancer patients: a systematic review and meta-analysis.
Wang S; Deng L; Chen J; Li Y; Zhong Y; Wang Y; Cao H
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17671-17682. PubMed ID: 37891407
[TBL] [Abstract][Full Text] [Related]
11. Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors.
Serrano JM; González I; Del Castillo S; Muñiz J; Morales LJ; Moreno F; Jiménez R; Cristóbal C; Graupner C; Talavera P; Curcio A; Martínez P; Guerra JA; Alonso JJ
Oncologist; 2015 Aug; 20(8):864-72. PubMed ID: 26185196
[TBL] [Abstract][Full Text] [Related]
12. Assessment of anthracycline-induced cardiotoxicity with electrocardiography.
Horacek JM; Jakl M; Horackova J; Pudil R; Jebavy L; Maly J
Exp Oncol; 2009 Jun; 31(2):115-7. PubMed ID: 19550402
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial.
Hao W; Liu S; Qin Y; Sun C; Chen L; Wu C; Bao Y
Trials; 2017 Aug; 18(1):386. PubMed ID: 28830541
[TBL] [Abstract][Full Text] [Related]
14. Burden of Cardiac Arrhythmias in Patients With Anthracycline-Related Cardiomyopathy.
Mazur M; Wang F; Hodge DO; Siontis BL; Beinborn DS; Villarraga HR; Lerman A; Friedman PA; Herrmann J
JACC Clin Electrophysiol; 2017 Feb; 3(2):139-150. PubMed ID: 29759386
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy.
Jacobs JEJ; Greason G; Mangold KE; Wildiers H; Willems R; Janssens S; Noseworthy P; Lopez-Jimenez F; Voigt JU; Friedman P; Van Aelst L; Vandenberk B; Attia ZI; Herrmann J
Eur J Prev Cardiol; 2024 Mar; 31(5):560-566. PubMed ID: 37943680
[TBL] [Abstract][Full Text] [Related]
16. Major cardiovascular adverse events in older adults with early-stage triple-negative breast cancer treated with adjuvant taxane + anthracycline versus taxane-based chemotherapy regimens: A SEER-medicare study.
Roy S; Lakritz S; Schreiber AR; Kuna EM; Bradley CJ; Kondapalli L; Diamond JR
Eur J Cancer; 2024 Jan; 196():113426. PubMed ID: 38000217
[TBL] [Abstract][Full Text] [Related]
17. First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis.
Jiang Y; Yin W; Zhou L; Yan T; Zhou Q; Du Y; Shen Z; Shao Z; Lu J
PLoS One; 2012; 7(3):e32474. PubMed ID: 22396769
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.
Fujii T; Le Du F; Xiao L; Kogawa T; Barcenas CH; Alvarez RH; Valero V; Shen Y; Ueno NT
JAMA Oncol; 2015 Dec; 1(9):1311-8. PubMed ID: 26402167
[TBL] [Abstract][Full Text] [Related]
19. Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.
Peddi P; Master SR; Dwary AD; Ravipati HP; Patel AH; Pasam A; Katikaneni PK; Shi R; Burton GV; Chu QD
Breast J; 2019 Jan; 25(1):62-68. PubMed ID: 30592128
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.
;
Lancet; 2023 Apr; 401(10384):1277-1292. PubMed ID: 37061269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
